Remarks on establishing a reliable supply of therapies, the urgent need to increase plasma collection across the EU, and the impact of the COVID-19 on the plasma donation system (as of October 2020), presented at the Global Plasma Summit.
This stakeholder supports EURACTIV's coverage of Plasma. This support enables EURACTIV to devote additional editorial resources to cover the topic more widely and deeply. EURACTIV's editorial content is independent from the views of its supporters.
The Plasma Protein Therapeutics Association (PPTA) is the global industry trade association with a strong European presence representing the private sector manufacturers of plasma-derived medicinal products (PDMPs), and privately-owned plasma donation centres, which includes more than 150 centres in Europe. PPTA is steadfast in its mission to promote the availability of, and access to, safe and effective plasma protein therapies for patients around the world.